Loredana Sarmati, MD

Full Professor in Infectious Diseases
Tor Vergata University of Rome, Italy

Disclosure(s): No financial relationships to disclose

Poster(s):

• 280 - Monoclonal Antibodies Against SARS-CoV-2 in Fragile Outpatients: Clinical and Laboratory Risk Factors and Protective Role of Vaccination
  Thursday, October 20, 2022

  12:15 PM – 1:30 PM US ET

• 1045 - Longitudinal Evaluation of the QuantiFERON-TB Gold Plus Assay in Hospitalized COVID-19 Patients with a First Indeterminate Result: Resolution of Inflammation and Restoration T-lymphocyte Counts and Interferon-gamma Production
  Friday, October 21, 2022

  12:15 PM – 1:30 PM US ET

• 1139 - Oral Antivirals Against SARS-CoV-2: a New Valid Strategy Against COVID-19
  Friday, October 21, 2022

  12:15 PM – 1:30 PM US ET

• 1438 - Latent tuberculosis infection (LTBI) in hematopoietic stem cell transplantation (HSCT) recipients: a retrospective Italian cohort study in Tor Vergata University Hospital, Rome.
  Friday, October 21, 2022

  12:15 PM – 1:30 PM US ET

• 1970 - SARS-CoV-2 T-cell specific responses in allogeneic hematopoietic stem cell transplant recipients after second and third dose of BNT162b2 mRNA vaccine
  Saturday, October 22, 2022

  12:15 PM – 1:30 PM US ET

• 2071 - HIV reservoir evaluation in GALT and PBMCs of virologically suppressed patients
  Saturday, October 22, 2022

  12:15 PM – 1:30 PM US ET